-
On Demand Medical Videos
-
Appropriate Patients for CABENUVA
External HCPs’ Opinions on Appropriate Selection of Patients for CABENUVA Treatment
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty CareExternal HCPs’ Opinions on Appropriate Selection of Patients for CABENUVA Treatment
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty Care -
Clinical Trials Data
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Cabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV HealthcareCabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare
ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, CabotegravirATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir
The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice
Paula Teichner, PharmD, AAHIVP, Regional Medical Lead
The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice
Paula Teichner, PharmD, AAHIVP, Regional Medical Lead
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs -
Congress Data
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
SOLAR Data Overview with Providers’ Thoughts of the Data
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Discussing CABENUVA Data at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Reasearch Center and Found of Midway Specialty Care CentersDiscussing CABENUVA Data at AIDS 2022
Bruce Gilliam, MD, FACP Sr. Medical Director, North American Medical Affairs
Dr. Moti Ramgopal, MD, FIDSA, FACP Associate Professor of Medicine Medical Director Midway Reasearch Center and Found of Midway Specialty Care Centers
Cabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV HealthcareCabenuva Post CROI 2022 Discussion
Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare
Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare
ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, CabotegravirATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice
Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir
Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs
Post-CROI 2021 Webinar
Andrew Zolopa, MD, VP, Head, North America Medical Affairs -
Data in Virologically Suppressed Patients
Every 2 Month Administration (ATLAS-2M)
Week 96 Results (CROI 2021, Video)
Week 96 Results (CROI 2021, Video)
Week 152 Results – Discussion and Application to Clinical Practice (Video)
Week 152 Results – Discussion and Application to Clinical Practice (Video)
-
Patient Reported Outcomes
HCPs’ Impressions on the Impact of SOLAR data in their practice
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty CareHCPs’ Impressions on the Impact of SOLAR data in their practice
Paula Teichner, PharmD, AAHIVP - Regional Medical Lead, Cabenuva, ViiV Healthcare
Dr. Rick Elion, MD - Washington Health Institute
Dr. Douglass Cunningham, DO - Pueblo Family Physicians
Dr. Cynthia Rivera, MD - Midway Specialty Care -
Safety Data
Weight and Lipid Changes (CROI 2021)
Weight and Lipid Changes (CROI 2021)
-
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Talk to a Medical Expert
Connect now with a live ViiV Medical Expert.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch